2023 RCPATH ACHIEVEMENT AWARD WINNERS 🏆
Huge effort by NHS Lothian infection team to deliver the "Infection bootcamp" over past 2 years. Well deserved recognition of the team's hard work 🎉
@NCAS_Aus Journal Club. Thanks @simgalimam for discussing his local health networks implementation of antibiotic hard stops, the benefits of reducing #DOTs and #LOTs and potential consequences when not reviewed. Read full publication here: bmcinfectdis.biomedcentral.c…
The official opening of the new and improved Junior Doctors mess at WGH today in Pentland Lodge. Thank you to all who made it happen especially our Chief Registrars and @NHSLothianMedEd team
Found my poster! 📸
Outcome: 40% REDUCTION in antibiotic prophylaxis for recurrent UTI within Bridgend locality! That’s >2,200 fewer antibiotics per year.
#UTIFriday#BSACSpring2023
Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and potentially irreversible side effects | European Medicines Agency europa.eu/!WGkDrR via @EMA_News
From @dr_vpatel910; @BrianChuSF; @UPenn_Allergy: A penicillin allergy testing service assessed penicillin allergy in patients with hematologic malignancies. All tested patients were negative. Patients who were challenged passed and were delabeled.
📄cup.org/42DWxvj
Are you an early-stage clinician interested in haematological #infections? The #ICDhaem course in our Infection Clinical Dilemmas series explores the common infection issues in haemato-oncology patients and the best ways to manage them 🦠 Join now! 👇 infectionclinicaldilemmas.co…
@ErinMcCreary giving us a unique argument for advocating IV to PO abx switch for serious infections ➡️ Saving massive amounts of nursing time! ⏰ (avg 22 min to administer IV vs. 80 seconds for PO) 🤯
@MAD_ID_ASP#MADID2023
"IV antibiotics hold some kind of “mythical status” for both the clinician and patient, especially when it comes to deeper infections like bacteremia and infective endocarditis.Mythology is, unfortunately, a poor proxy for data, but luckily evidence-based alternatives exist!"🎯
"Choosing the less safe, not more effective IV-only alternative may be akin to administering a proverbial “placebo” to treat the clinician’s or patient’s own anxiety"
Please RT
Defining the Optimal Duration of Therapy for Hospitalized Patients With Complicated Urinary Tract Infections and Associated Bacteremia academic.oup.com/cid/article…
Another study that shows the low utility of urine culture in those without urinary symptoms, even for a high risk patient group (HSCT recipients with neutropenic fever)